Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/47460
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | NICHOLS, Emma | - |
dc.date.accessioned | 2022-06-20T15:43:14Z | - |
dc.date.available | 2022-06-20T15:43:14Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | NEUROEPIDEMIOLOGY, v.55, n.4, p.286-296, 2021 | - |
dc.identifier.issn | 0251-5350 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/47460 | - |
dc.description.abstract | Background: In light of the increasing trend in the global number of individuals affected by dementia and the lack of any available disease-modifying therapies, it is necessary to fully understand and quantify the global burden of dementia. This work aimed to estimate the proportion of dementia due to Down syndrome, Parkinson's disease, clinical stroke, and traumatic brain injury (TBI), globally and by world region, in order to better understand the contribution of clinical diseases to dementia prevalence. Methods: Through literature review, we obtained data on the relative risk of dementia with each condition and estimated relative risks by age using a Bayesian meta-regression tool. We then calculated population attributable fractions (PAFs), or the proportion of dementia attributable to each condition, using the estimates of relative risk and prevalence estimates for each condition from the Global Burden of Disease Study 2019. Finally, we multiplied these estimates by dementia prevalence to calculate the number of dementia cases attributable to each condition. Findings: For each clinical condition, the relative risk of dementia decreased with age. Relative risks were highest for Down syndrome, followed by Parkinson's disease, stroke, and TBI. However, due to the high prevalence of stroke, the PAF for dementia due to stroke was highest. Together, Down syndrome, Parkinson's disease, stroke, and TBI explained 10.0% (95% UI: 6.0-16.5) of the global prevalence of dementia. Interpretation: Ten percent of dementia prevalence globally could be explained by Down syndrome, Parkinson's disease, stroke, and TBI. The quantification of the proportion of dementia attributable to these 4 conditions constitutes a small contribution to our overall understanding of what causes dementia. However, epidemiological research into modifiable risk factors as well as basic science research focused on elucidating intervention approaches to prevent or delay the neuropathological changes that commonly characterize dementia will be critically important in future efforts to prevent and treat disease. | eng |
dc.language.iso | eng | - |
dc.publisher | KARGER | eng |
dc.relation.ispartof | Neuroepidemiology | - |
dc.rights | restrictedAccess | eng |
dc.subject | Dementia | eng |
dc.subject | Global health | eng |
dc.subject | Burden of disease | eng |
dc.subject | Meta-analysis | eng |
dc.subject | Public health | eng |
dc.subject.other | alzheimers-disease | eng |
dc.subject.other | risk-factors | eng |
dc.subject.other | pathologies | eng |
dc.subject.other | prevalence | eng |
dc.title | The Burden of Dementia due to Down Syndrome, Parkinson's Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019 | eng |
dc.type | article | eng |
dc.rights.holder | Copyright KARGER | eng |
dc.contributor.groupauthor | GBD 2019 Dementia Collaborators | - |
dc.contributor.groupauthor | WANG, Yuan Pang | - |
dc.identifier.doi | 10.1159/000515393 | - |
dc.identifier.pmid | 34182555 | - |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.description.beginpage | 286 | - |
hcfmusp.description.endpage | 296 | - |
hcfmusp.description.issue | 4 | - |
hcfmusp.description.volume | 55 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000675325100005 | - |
hcfmusp.origem.id | 2-s2.0-85110158264 | - |
hcfmusp.publisher.city | BASEL | eng |
hcfmusp.publisher.country | SWITZERLAND | eng |
hcfmusp.relation.reference | Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527 | eng |
hcfmusp.relation.reference | Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9 | eng |
hcfmusp.relation.reference | American Psychiatric Association, 2000, CORTEX, V4th, DOI 10.1016/j.cortex.2018.05.006 | eng |
hcfmusp.relation.reference | Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b | eng |
hcfmusp.relation.reference | Ballard C, 2016, LANCET NEUROL, V15, P622, DOI 10.1016/S1474-4422(16)00063-6 | eng |
hcfmusp.relation.reference | Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494 | eng |
hcfmusp.relation.reference | Brayne C, 2009, J ALZHEIMERS DIS, V18, P645, DOI 10.3233/JAD-2009-1182 | eng |
hcfmusp.relation.reference | Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381 | eng |
hcfmusp.relation.reference | Corraini P, 2017, STROKE, V48, P180, DOI 10.1161/STROKEAHA.116.015242 | eng |
hcfmusp.relation.reference | Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017 | eng |
hcfmusp.relation.reference | Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13 | eng |
hcfmusp.relation.reference | Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5 | eng |
hcfmusp.relation.reference | Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346 | eng |
hcfmusp.relation.reference | Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659 | eng |
hcfmusp.relation.reference | James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224 | eng |
hcfmusp.relation.reference | Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556 | eng |
hcfmusp.relation.reference | Kuzma E, 2018, ALZHEIMERS DEMENT, V14, P1416, DOI 10.1016/j.jalz.2018.06.3061 | eng |
hcfmusp.relation.reference | Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6 | eng |
hcfmusp.relation.reference | Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787 | eng |
hcfmusp.relation.reference | Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3 | eng |
hcfmusp.relation.reference | Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180 | eng |
hcfmusp.relation.reference | Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063 | eng |
hcfmusp.relation.reference | MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617 | eng |
hcfmusp.relation.reference | Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9 | eng |
hcfmusp.relation.reference | Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534 | eng |
hcfmusp.relation.reference | Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94 | eng |
hcfmusp.relation.reference | Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930 | eng |
hcfmusp.relation.reference | OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120 | eng |
hcfmusp.relation.reference | Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503 | eng |
hcfmusp.relation.reference | Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007 | eng |
hcfmusp.relation.reference | Prince MJ., 2015, WORLD ALZHEIMER REPO | eng |
hcfmusp.relation.reference | Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142 | eng |
hcfmusp.relation.reference | Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24 | eng |
hcfmusp.relation.reference | Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210 | eng |
hcfmusp.relation.reference | Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166 | eng |
hcfmusp.relation.reference | Waite LM, 2015, AUST PRESCR, V38, P60, DOI 10.18773/austprescr.2015.018 | eng |
hcfmusp.relation.reference | Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6 | eng |
hcfmusp.relation.reference | WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310 | eng |
hcfmusp.relation.reference | World Health Organization WHO, 1992, ICD 10 CLASS MENT BE | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1423-0208 | - |
hcfmusp.citation.scopus | 15 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/IPq Artigos e Materiais de Revistas Científicas - LIM/23 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_NICHOLS_The_Burden_of_Dementia_due_to_Down_Syndrome_2021.PDF Restricted Access | publishedVersion (English) | 499.37 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.